Iambic TherapeuticsPrice range

Iambic Therapeutics sets an IPO price range

Iambic Therapeutics sets an IPO price range (October 8, 2026).

Iambic Therapeutics develops a unified platform for drug discovery and development, covering hit identification, lead optimization and clinical developability.

Offering details

Price range
$15.0 to $17.0
Shares offered
9.4M
Exchange
Nasdaq Global Select Market
Proposed ticker
IAM

IPO timeline

  1. files for an IPO

    Iambic Therapeutics

  2. sets an IPO price range

    Iambic Therapeutics